New Research Reports

Management said that SUNP aims to sustain its outperformance in the domestic formulation (DF) segment through increased doctor engagement, new launches, addition of field force and strengthening the brand recall of its existing products.

Pace Digitek Ltd. (PDL) is a telecom infrastructure solution provider with a primary focus on the telecom infrastructure industry including telecom towers and optical fibre cables. PDL generates revenue under three verticals namely telecommunications, Energy, Information & communication technology (ICT). With the acquisition of GE Power Electronics India in 2014, the company commenced end to end manufacturing of direct current systems which are tailored for telecom tower companies and operators helping it in energy management...

BMW Ventures Ltd. (BMWV) is engaged in trading/distribution of steel products, tractor engines and spare parts; manufacturing of PVC pipes and roll forming; and fabrication of pre-engineered buildings (PEB) and steel girders. The company specializes in the distribution of long and flat steel products across Bihar, India. As of Mar'25, the company's dealer network...

Q1FY2026 Consolidated revenue of Rs. 7,042 crore was up 49% y-o-y. Revenues increased due to strong volume growth in the fertilizer and the crop protection business and increase in subsidy.

We hosted Karur Vysya Bank (KVB)’s senior management in Chennai. Investors discussions were centred around the SME portfolio’s health, especially export-oriented units amidst higher US tariffs and change, if any, in the operating environment for the SME units.

Retail Research

Retail Research

BKT's sales volume was impacted by tariff-related disruptions, leading to a volatile ordering cycle in April. Ongoing trade tensions and geopolitical challenges in key export markets have dampened customer sentiment. However, the company expects the ordering cycle to normalise with a permanent tariff structure. BKT has been gaining brand acceptance in the Indian market and aims to enhance it further by launching into the PCR and CV segments. With expansions in the OHT segment...

We maintain our BUY rating on the stock and value it at 20x FY27E EPS with a TP of Rs 1,030/share, implying an upside of 19% from the CMP.